Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CAR-T
Biotech
ASCO: Legend scientific founder returns with new CAR-T ambition
With Wondercel Therapeutics, Frank Fan hopes an off-the-shelf CAR-T platform can tackle production scalability without the need for gene editing.
Angus Liu
May 29, 2026 2:00pm
Has Novartis’ T-Charge push been overtaken by in vivo CAR-Ts?
May 22, 2026 8:28am
Liminatus pays $320M in stock for CAR-T biotech InnocsAI
May 21, 2026 8:09am
Kyverna begins rolling FDA submission for autoimmune CAR-T in SPS
May 12, 2026 4:27pm
After buyout, Gilead is laying off Arcellx staff on both coasts
May 5, 2026 3:12pm
J&J axes $5B CAR-T dream months after touting efficacy edge
May 1, 2026 8:26am
